Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zhejiang Hisun Pharmaceutical Co Ltd cancels plan of issuing convertible bonds and announces private placement


Friday, 29 Nov 2013 07:00pm EST 

Zhejiang Hisun Pharmaceutical Co Ltd:Says to stop application for the issuance of convertible bonds, and to fund from private placement of common shares instead.Says to issue up to 139.50 million A shares of common stock with par value of 1 yuan per share.Says an issue price of no less than 14.26 yuan per share, to raise up to 1.988 billion yuan.Says the proceeds will be used for investment in three projects.